Skip to content

Cancer as Condensate Collapse: A Ginzburg-Landau Framework for Redifferentiation Therapy

Jean-Paul Niko · RTSG BuildNet · 2026


Abstract

We propose that cancer is a Ginzburg-Landau (GL) condensate collapse — a phase transition in which a cell's identity order parameter \(W_0\) drops to zero, erasing its differentiation program. In this framework, metastasis is condensate propagation, aging is slow condensate erosion, and cure is condensate restoration. The framework is not metaphorical: it makes quantitative predictions about the relationship between condensate strength and cancer incidence (recovering the Gompertz law), identifies the mechanism by which all-trans retinoic acid (ATRA) cures acute promyelocytic leukemia (APL) as condensate restoration, and outlines a research program for extending this approach to all cancer types.


1. Introduction

Cancer research has produced extraordinary molecular detail — thousands of driver mutations, dozens of signaling pathways, hundreds of therapeutic targets — yet the field lacks a unifying physical theory that explains why cells lose their identity. We propose that the Ginzburg-Landau framework, which successfully describes phase transitions in superconductivity, superfluidity, and the Higgs mechanism, also describes the phase transition in which a differentiated cell becomes cancerous.

The core claim: every differentiated cell type maintains a condensate — an order parameter \(W_0 \neq 0\) that encodes its identity (hepatocyte, neuron, granulocyte). Cancer occurs when this condensate collapses (\(W_0 \to 0\)). Cure occurs when it is restored.

This is not a new equation. It is the same GL action that governs the rest of RTSG:

\[S[W] = \int \left( |\partial W|^2 + \alpha|W|^2 + \frac{\beta}{2}|W|^4 \right) d\mu\]

2. The Condensate Model of Cellular Identity

2.1 The Order Parameter

Each differentiated cell type \(\tau\) has a cell-type-specific Will field condensate \(W_\tau\) with vacuum expectation value:

\[W_0^\tau = \sqrt{-\alpha_\tau / \beta_\tau}\]

This condensate encodes the cell's identity — its differentiation program, its gene expression profile, its functional role. The condensate is maintained by an energy barrier:

\[\Delta E_{\text{barrier}}^\tau \propto (W_0^\tau)^2 = \frac{\alpha_\tau^2}{\beta_\tau}\]

2.2 Cancer as Phase Transition

Cancer occurs when \(\alpha\) crosses from negative to positive:

  • Healthy cell: \(\alpha < 0 \implies W_0 \neq 0\) (condensate present, identity maintained)
  • Cancer cell: \(\alpha > 0 \implies W_0 = 0\) (condensate collapsed, identity lost)

The cell does not "know what it is" anymore. It reverts to undifferentiated proliferation — the default state when the identity condensate is absent.

2.3 What Drives the Phase Transition

In molecular terms, the sign of \(\alpha\) is determined by the balance between differentiation-maintaining signals (transcription factors, epigenetic marks, niche signals) and destabilizing forces (mutations, epigenetic drift, microenvironmental stress). When the destabilizing forces overwhelm the maintaining forces, \(\alpha\) flips sign and the condensate collapses.

This maps directly onto known cancer biology: driver mutations (TP53 loss, RAS activation, MYC amplification) are mechanisms by which \(\alpha\) is pushed toward positive values.


3. The Gompertz Law from GL Barrier Erosion

The Gompertz law — the empirical observation that cancer incidence rises exponentially with age — has no satisfying mechanistic explanation in standard oncology. The GL framework derives it.

Aging is the slow erosion of the condensate:

\[W_0(t) = W_0(0) \cdot e^{-\gamma t}\]

where \(\gamma\) is the condensate erosion rate (driven by accumulated epigenetic drift, telomere shortening, stem cell exhaustion, etc.).

The energy barrier to cancer therefore decays as:

\[\Delta E_{\text{barrier}}(t) \propto W_0(t)^4 \propto e^{-2\gamma t}\]

The rate of barrier crossing (Kramers' theory) gives:

\[h(t) \propto e^{-\Delta E / kT} \propto e^{e^{-2\gamma t} / kT}\]

For the regime where the barrier is still large relative to \(kT\), this approximates:

\[h(t) \propto e^{-\Delta E(t)/kT} \approx A e^{bt}\]

which is the Gompertz law with \(b \approx 4\gamma \cdot \Delta E_0/(kT)\).

Prediction: Maintaining \(W_0\) (condensate strength) is anti-aging. Any intervention that stabilizes the differentiation program — whether molecular, epigenetic, or environmental — reduces cancer incidence by maintaining the GL barrier.


4. ATRA and APL: The Proof of Concept

Acute promyelocytic leukemia (APL) is caused by the PML-RARα fusion protein, which blocks granulocyte differentiation. In GL terms: PML-RARα drives \(\alpha_{\text{granulocyte}}\) positive, collapsing the granulocyte identity condensate.

All-trans retinoic acid (ATRA) degrades PML-RARα, restoring the granulocyte differentiation program. In GL terms: ATRA restores \(\alpha_{\text{granulocyte}} < 0\), the condensate reforms, and the cells remember what they are. They differentiate into mature granulocytes and undergo normal apoptosis.

The result: >95% cure rate. Not remission. Cure.

This is not one data point. It is the proof of concept for the entire framework: find the molecule that restores \(\alpha < 0\) for the specific cell type, and the cancer is cured by redifferentiation.


5. The Research Program

5.1 Condensate Profiling

Definition (I-vector coherence): The I-vector coherence profile of a cell type \(\tau\) is the vector \(\mathbf{c}_\tau = (g_1, g_2, \ldots, g_k)\) where \(g_i\) measures the expression level of the \(i\)-th identity gene relative to the undifferentiated baseline. High coherence (\(\|\mathbf{c}_\tau\| \gg 0\)) corresponds to strong condensate (\(W_0 \gg 0\)); loss of coherence signals condensate erosion.

For each cell type, measure the I-vector coherence profile — the set of gene expression patterns, epigenetic marks, and signaling states that constitute the identity condensate. This gives \(W_0^\tau\) for each type \(\tau\).

5.2 Collapse Mapping

For each cancer type, identify which condensate breaks and what breaks it. Map the molecular mechanism by which \(\alpha\) flips sign. This is a finite (though large) enumeration problem.

5.3 Restoration Screening

For each collapsed condensate, screen for molecules or interventions that restore \(\alpha < 0\). ATRA worked for APL. The same logic applies to every cancer type — the question is which molecule restores which condensate.

5.4 Predictions

  1. Every cancer type should be characterizable by a specific condensate order parameter
  2. Restoration of that parameter should induce redifferentiation
  3. Cancer incidence by age should follow the Gompertz-GL curve for each type
  4. Interventions that stabilize \(W_0\) (e.g., maintaining epigenetic fidelity) should reduce cancer incidence across all types

6. Relationship to Existing Frameworks

Framework GL Interpretation
Hallmarks of Cancer (Hanahan & Weinberg) Each hallmark is a specific mechanism by which \(\alpha\) is pushed positive
Cancer Stem Cell hypothesis CSCs are cells with partially collapsed condensate — enough identity to self-renew, not enough to differentiate
Epigenetic reprogramming Epigenetic marks are components of \(W_0\); reprogramming = condensate manipulation
Immune checkpoint therapy Immune recognition depends on condensate surface markers; collapsed condensate evades detection
Warburg effect Metabolic reprogramming follows from identity loss — undifferentiated cells default to glycolysis

The GL framework does not replace these. It unifies them under a single order parameter.


7. Connection to the RTSG Program

Cancer is not an isolated application. In RTSG, the same GL action governs:

  • Quantum gravity: Graviton = Goldstone boson of broken U(1) instantiation symmetry
  • Yang-Mills: Mass gap = \(1/\xi_W\) (correlation length of the condensate)
  • Consciousness: CS operator strength \(\propto W_0\)
  • Cancer: Disease = condensate collapse; cure = restoration
  • Aging: Slow erosion of \(W_0\)

Same equation. Every scale. The cancer application is the most immediately testable because the molecular tools already exist.


8. Conclusion

Cancer is a phase transition. The GL framework provides a physically rigorous, quantitatively predictive, and experimentally testable theory of what cancer is — not at the level of molecular pathways (which vary), but at the level of the underlying phase structure (which is universal). The research program is concrete: profile the condensate, map the collapse, find the restoration molecule. ATRA proved this works for one cancer type. The framework predicts it works for all of them.


References


Jean-Paul Niko · jeanpaulniko@proton.me · smarthub.my